AX-2026-043613
CJC-1295 with DAC · 10 mg declared · PolyPeptide Group (Hangzhou) Co., Ltd. · lot PPG-2603-Y7499
- Report ID
- AX-2026-043613
- Compound
- CJC-1295 with DAC
- Compound class
- Growth-hormone axis peptides
- Supplier
- PPG — PolyPeptide Group (Hangzhou) Co., Ltd.
- Batch / lot
- PPG-2603-Y7499
- Declared label claim
- 10mg
- Laboratory
- PeptideMeter
- Assay date
- 02 Mar 2026
- Submitted
- 22 Mar 2026
- Quarter
- 2026-Q1
- Submitter
- amber_glass
- Sample provenance
- Supplier-supplied
Results
Measured against the index acceptance specification for the growth-hormone axis peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.
| Parameter | Method | Result | Unit | Index spec | |
|---|---|---|---|---|---|
| Purity | RP-HPLC, 28 min gradient, 214 nm | 99.25 | % area | ≥ 97.5 | PASS |
| Total impurities | RP-HPLC, sum of reported peaks | 0.75 | % area | ≤ 2.5 | PASS |
| Largest single impurity | RP-HPLC — hydrolysed maleimide (+18 Da) | 0.32 | % area | ≤ 1.00 | PASS |
| Identity — theoretical monoisotopic mass | calculated from molecular formula | 3644.9748 | Da | — | NOT TESTED |
| Identity — observed monoisotopic mass | LC-MS, high resolution (ESI-TOF/QTOF) | 3644.9726 | Da | — | NOT TESTED |
| Mass accuracy | observed vs theoretical | -0.6 | ppm | ± 15 | PASS |
| Total peptide content | by difference from the gravimetric mass balance | 88.76 | %w/w | — | NOT TESTED |
| Target-compound content | total peptide content × purity | 88.09 | %w/w | — | NOT TESTED |
| Gross fill (as weighed) | five-place balance, under nitrogen | 10.69 | mg | 10 mg declared | NOT TESTED |
| Recovered target peptide | gross fill × target content | 9.417 | mg | 10 mg claim | NOT TESTED |
| Recovery against label claim | recovered ÷ claim | 94.2 | % | 90.0 – 110.0 | PASS |
| Water content | Karl Fischer, coulometric, duplicate | 6.12 | % | ≤ 9.0 | PASS |
| Counter-ion (acetate) | anion-exchange ion chromatography | 4.85 | % | ≤ 12.0 | PASS |
| Residual solvent + inorganic residue | estimated — see /methods/residual-solvents-q3c/ | 0.27 | % | — | NOT TESTED |
| Endotoxin | not ordered on this submission | not determined | — | ≤ 5.0 | NOT TESTED |
| Sterility | not ordered on this submission | not determined | — | no growth | NOT TESTED |
| Appearance | visual, diffuse light, black and white background | White lyophilised cake, intact | — | white to off-white intact cake | PASS |
| Reconstitution clarity | reconstituted per submitter procedure | Clear, colourless, no visible particulates | — | clear, no visible particulates | PASS |
| pH (reconstituted, 1 mg/mL) | potentiometric, two-point calibration | 4.82 | — | 2.5 – 8.0 | PASS |
| Retention time (observed) | RP-HPLC, 28 min gradient | 13.56 | min | 13.72 ± 0.35 (normalised) | PASS |
| Peak asymmetry (10 % height) | Ph. Eur. 2.2.46 | 1.01 | — | 0.80 – 1.50 | PASS |
| Plate count, main peak | N = 5.54 (t/w½)² | 84,772 | — | ≥ 20,000 | PASS |
| Resolution to nearest impurity | vs deamidated (+1 Da) | 1.27 | — | no index criterion | REPORTED |
Chromatogram and peak integration
The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.
| # | Peak | RT | Area (µV·s) | % area | Δ mass (Da) |
|---|---|---|---|---|---|
| 1 | CJC-1295 with DAC — main peak | 13.56 | 4,823,858 | 99.25 | — |
| 2 | hydrolysed maleimide (+18 Da) | 12.98 | 15,553 | 0.32 | +18.011 |
| 3 | deamidated (+1 Da) | 13.32 | 13,123 | 0.27 | +0.984 |
| 4 | mod-GRF (1-29) (−279 Da) | 11.92 | 4,860 | 0.10 | -279.235 |
| 5 | maleimide dimer | 15.82 | 2,916 | 0.06 | +3644.975 |
| Closure check — purity + Σ impurities | 100.00 | CLOSES | |||
Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.
Mass spectrum and identity
Theoretical monoisotopic mass 3644.9748 Da, computed from C165H269N47O46. All ppm figures on this site are against monoisotopic values — see why that matters.
| Charge | Theoretical m/z | Observed m/z | Δ m/z | Rel. abundance (%) |
|---|---|---|---|---|
| 5+ | 730.0022 | 730.0018 | -0.0004 | 8.4 |
| 4+ | 912.2510 | 912.2504 | -0.0006 | 54.7 |
| 3+ | 1215.9989 | 1215.9981 | -0.0008 | 100.0 |
| 2+ | 1823.4947 | 1823.4936 | -0.0011 | 53.1 |
Gravimetric mass balance
Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.
| Component | Determination | %w/w of cake |
|---|---|---|
| Water | Karl Fischer | 6.12 |
| Counter-ion (acetate) | ion chromatography | 4.85 |
| Residual solvent + inorganic residue | estimated | 0.27 |
| Total peptide content | by difference | 88.76 |
| Total | 100.00 CLOSES | |
Supplier certificate, as declared
The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.
| Figure | Supplier COA | This report | Index note |
|---|---|---|---|
| Purity (% area) | 99.07 | 99.25 | divergence -0.38 pp vs batch median |
| Total impurities (% area) | 0.93 | 0.75 | |
| Largest single impurity (% area) | not stated | 0.32 | |
| Water (%) | 4.2 | 6.12 | |
| Counter-ion (%) | not stated | 4.85 | |
| Peptide content (%w/w) | 91.0 | 88.76 | |
| Endotoxin (EU/mg) | not stated | not determined | |
| Method stated on certificate | NO | — | no method section — the result cannot be reconciled against any other |
Provenance and caveats
Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.
- Sample provenance
- Supplier-supplied
- Evidentiary weight
- Weaker evidence. Read with the caveat below.
- Chain of custody
- Supplier despatch → laboratory direct (courier, cold pack, 2 d) → assay. Submitter did not handle the vial.
- Assay date
- 02 Mar 2026
- Submitted to the index
- 22 Mar 2026
- Laboratory
- PeptideMeter, Tallinn, Estonia
- Method basis
- 28 min gradient · high-resolution MS
- Verification status
- VERIFIED
Annotations
No annotations on this record. Annotations are short signed technical comments from index contributors; see how to contribute.
Related records
Same batch — lot PPG-2603-Y7499 n=2
| Report | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043612 | PPG-2603-Y7499 | Medutest | 2026-Q1 | 99.65 | 5.70 | 93.8 | Buyer-sourced | 0 | PASS |
Cross-sections
| Report | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041681 | TFS | TFS-{CAT}-9675 | PeptideMeter | 2026-Q3 | 98.82 | 3.67 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041867 | SinoPep | SNP-2607-C3886 | Janoshik | 2026-Q3 | 99.24 | 5.12 | — | Laboratory-retained | 1 | FAIL |
| AX-2026-041682 | TFS | TFS-{CAT}-9675 | Nordanalyt | 2026-Q3 | 98.94 | 3.24 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041683 | TFS | TFS-{CAT}-9675 | Medutest | 2026-Q3 | 98.68 | 3.46 | 97.0 | Buyer-sourced | 0 | PASS |
| AX-2026-043471 | BCH | BCH-2607-H5235 | Janoshik | 2026-Q3 | 97.46 | 5.48 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-043477 | BCH | BCH-2607-H5235 | VendorInvestigate | 2026-Q3 | 97.62 | 5.32 | 99.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043470 | BCH | BCH-2607-H5235 | Janoshik | 2026-Q3 | 97.76 | 6.11 | 99.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043478 | BCH | BCH-2607-H5235 | PeptideMeter | 2026-Q3 | 97.63 | 5.42 | 90.1 | Buyer-sourced | 1 | MARGINAL |
| Report | Compound | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043598 | Tesamorelin | PPG-2608-A6835 | Kestrel | 2026-Q3 | 98.91 | 2.56 | 100.3 | Buyer-sourced | 1 | FAIL |
| AX-2026-043597 | Tesamorelin | PPG-2608-A6835 | Janoshik | 2026-Q3 | 98.54 | 1.15 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043596 | Tesamorelin | PPG-2608-A6835 | PeptideMeter | 2026-Q3 | 98.74 | 1.83 | 105.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043605 | Retatrutide | PPG-2604-X7060 | Janoshik | 2026-Q2 | 98.17 | 4.29 | 99.7 | Buyer-sourced | 0 | PASS |
| AX-2026-043601 | Retatrutide | PPG-2604-X7060 | Janoshik | 2026-Q2 | 98.28 | 3.96 | 95.3 | Buyer-sourced | 0 | PASS |
| AX-2026-043668 | AOD-9604 | PPG-2602-W8018 | PeptideMeter | 2026-Q2 | 99.47 | 3.06 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043670 | AOD-9604 | PPG-2602-W8018 | PeptideMeter | 2026-Q2 | 99.56 | 2.71 | 104.5 | Buyer-sourced | 0 | PASS |
| AX-2026-043630 | CJC-1295 (no DAC) | PPG-2512-D7211 | Janoshik | 2026-Q2 | 99.66 | 5.11 | 92.5 | Buyer-sourced | 0 | PASS |